Omidria 1-0.3% vial 4ML
Ended Awarded
- Contract number
- SPE2DX25F6AGQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,175
Award facts
- Contract value 100% obligated
- $7,174.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,174.74 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025, for the supply of Omidria 1-0.3% vials (4ML). This delivery order is issued under the company's larger single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. The contract was awarded without a set-aside designation, with performance scheduled to be completed by October 14, 2025, at the company's location in Park Ridge, Illinois.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively in Defense Logistics Agency procurement markets while providing direct distribution of prescription drugs and specialized medical products to Department of Defense healthcare sites. The company maintains a robust portfolio of pharmaceutical contract awards covering an extensive array of medical products including prescription medications, biologics, and medical consumables, positioning it as a key distributor of branded and generic pharmaceutical items to military and federal healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6AGQ?
SPE2DX25F6AGQ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 22, 2025.
How much is contract SPE2DX25F6AGQ worth?
The government has obligated $7,175 on SPE2DX25F6AGQ.
Is contract SPE2DX25F6AGQ an order under another contract?
Yes. SPE2DX25F6AGQ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGQ competed?
The extent of competition for SPE2DX25F6AGQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award